Surprisingly, higher expressions of DNMT3B and EZH2 are reported in ovarian cancer and, as per RNA-seq results, CHD4 expression is positively correlated with EZH2 in ovarian cancer patients. This evidence concerns the gene EZH2 and ovarian carcinoma.